L-Methylfolate for ADHD: No Evidence of Benefit
Based on the highest quality evidence available, L-methylfolate should NOT be used as an adjunct treatment for ADHD, as it provides no therapeutic benefit and may actually reduce the effectiveness of standard ADHD medications.
Evidence Against L-Methylfolate Use
The most definitive study on this question is a 2019 double-blind, placebo-controlled randomized trial that directly tested L-methylfolate (15 mg) combined with methylphenidate in 44 adults with ADHD 1. This study found:
- No improvement in ADHD symptoms compared to placebo
- No improvement in executive function measures
- No improvement in emotional dysregulation, social adjustment, or work productivity
- Higher methylphenidate doses were required in patients taking L-methylfolate (suggesting reduced medication efficacy)
- The only positive finding was a minor improvement on one adaptive dimension scale, which is clinically insignificant
A second randomized controlled trial in 49 children with ADHD tested folic acid (5 mg) combined with methylphenidate over 8 weeks 2. Results showed:
- No difference between groups in ADHD symptom reduction
- No difference in treating aggression
- No improvement in quality of life beyond methylphenidate alone
- Both groups improved equally, indicating folic acid added nothing
Guideline Recommendations
Current evidence-based guidelines for ADHD pharmacological treatment do not include L-methylfolate or folic acid supplementation 3, 4. The established treatment algorithm is:
First-line: Stimulants (methylphenidate or amphetamines/lisdexamfetamine)
Second-line: Non-stimulants (atomoxetine, guanfacine, clonidine)
No role for folate supplementation at any treatment stage
Important Caveats
The FDA drug label for L-methylfolate notes potential drug interactions 5:
- High-dose folic acid may decrease serum levels of first-generation anticonvulsants
- While no decreased effectiveness has been reported specifically with L-methylfolate, caution is advised
- The exploratory finding that L-methylfolate was associated with higher methylphenidate dosing requirements 1 raises concern about potential interference with stimulant efficacy
Clinical Bottom Line
There is no justification for prescribing L-methylfolate as an adjunct to ADHD treatment. The evidence shows it provides no benefit and may potentially reduce medication effectiveness. Stick to evidence-based pharmacological treatments: stimulants as first-line therapy, with non-stimulants reserved for cases where stimulants are ineffective, not tolerated, or contraindicated 4, 6.